MedTrace Logo

Comparison of Cervical Cancer Screening Tests in HIV-infected Women in Lusaka, Zambia

NCT02688816 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2016-02-23

No results posted yet for this study

Summary

This study will compare the test performance characteristics of visual inspection with acetic acid (VIA), Xpert HPV, and OncoE6 in HIV-infected women, to inform the possible inclusion of these molecular tests in future cervical cancer screening

Conditions

Interventions

DEVICE

Xpert HPV

Point-of-care HPV DNA PCR test

DEVICE

OncoE6

Point-of-care E6 oncoprotein test

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Carla Chibwesha, MD

    lead OTHER

Principal Investigators

  • Carla Chibwesha, MD · University of North Carolina, Chapel Hill

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • Zambia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02688816 on ClinicalTrials.gov